rams and significantly reducing or terminating investments into others. Examples of this type of investment include Intarcia Therapeutics (NLV-I) and Synageva Biopharma (NLV-II, reverse merger to become public - November, 2011, NASDAQ: GEVA,; exited at 7.3x). e Restructuring & Recapitalizing Public Compani